Welsbach Technology Metals Acquisition (NASDAQ:EMAT – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.02) earnings per share (EPS) for the quarter, Zacks reports. The business had revenue of $1.88 million for the quarter.
Welsbach Technology Metals Acquisition Trading Down 4.0%
NASDAQ:EMAT opened at $7.99 on Friday. The stock has a 50-day simple moving average of $8.16. Welsbach Technology Metals Acquisition has a 1-year low of $5.50 and a 1-year high of $24.08.
Analyst Ratings Changes
EMAT has been the topic of a number of recent research reports. Weiss Ratings initiated coverage on shares of Welsbach Technology Metals Acquisition in a research report on Tuesday, January 27th. They issued a “sell (d-)” rating on the stock. Clear Str raised shares of Welsbach Technology Metals Acquisition to a “strong-buy” rating in a research report on Wednesday, February 18th. Finally, Wall Street Zen raised shares of Welsbach Technology Metals Acquisition from a “sell” rating to a “hold” rating in a research report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.
About Welsbach Technology Metals Acquisition
Welsbach Technology Metals Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on the technology metals and energy transition metals sectors. Welsbach Technology Metals Acquisition Corp. was incorporated in 2021 and is based in Lombard, Illinois.
Further Reading
- Five stocks we like better than Welsbach Technology Metals Acquisition
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Welsbach Technology Metals Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welsbach Technology Metals Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
